The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.

BACKGROUND It has been suggested that a low dietary intake of antioxidant vitamins and minerals increases the incidence rate of cardiovascular disease and cancer. To date, however, the published results of randomized, placebo-controlled trials of supplements containing antioxidant nutrients have not provided clear evidence of a beneficial effect. We tested the efficacy of nutritional doses of supplementation with a combination of antioxidant vitamins and minerals in reducing the incidence of cancer and ischemic cardiovascular disease in the general population. METHODS The Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) study is a randomized, double-blind, placebo-controlled primary prevention trial. A total of 13 017 French adults (7876 women aged 35-60 years and 5141 men aged 45-60 years) were included. All participants took a single daily capsule of a combination of 120 mg of ascorbic acid, 30 mg of vitamin E, 6 mg of beta carotene, 100 mug of selenium, and 20 mg of zinc, or a placebo. Median follow-up time was 7.5 years. RESULTS No major differences were detected between the groups in total cancer incidence (267 [4.1%] for the study group vs 295 [4.5%] for the placebo group), ischemic cardiovascular disease incidence (134 [2.1%] vs 137[2.1%]), or all-cause mortality (76 [1.2%] vs 98 [1.5%]). However, a significant interaction between sex and group effects on cancer incidence was found (P = .004). Sex-stratified analysis showed a protective effect of antioxidants in men (relative risk, 0.69 [95% confidence interval [CI], 0.53-0.91]) but not in women (relative risk, 1.04 [95% CI, 0.85-1.29]). A similar trend was observed for all-cause mortality (relative risk, 0.63 [95% CI, 0.42-0.93] in men vs 1.03 [95% CI, 0.64-1.63] in women; P = .11 for interaction). CONCLUSIONS After 7.5 years, low-dose antioxidant supplementation lowered total cancer incidence and all-cause mortality in men but not in women. Supplementation may be effective in men only because of their lower baseline status of certain antioxidants, especially of beta carotene.

[1]  P Galan,et al.  A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants. , 1998, Controlled clinical trials.

[2]  Kathleen M. Fairfield,et al.  Vitamins for chronic disease prevention in adults: clinical applications. , 2002, JAMA.

[3]  Lawrence A. Yannuzzi,et al.  Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .

[4]  R. Scholten,et al.  The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines , 1999, Annals of Internal Medicine.

[5]  A. Diplock.  Antioxidant nutrients and disease prevention: an overview. , 1991, The American journal of clinical nutrition.

[6]  J. Hanlon,et al.  Predictors of Nutritional Supplement Use by the Elderly , 1996, Pharmacotherapy.

[7]  A F Subar,et al.  Nonvitamin, nonmineral dietary supplements: issues and findings from NHANES III. , 2000, Journal of the American Dietetic Association.

[8]  B. Sibbald,et al.  Ephedra/ephedrine: cardiovascular and CNS effects. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  R. Kessler,et al.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use. , 1993, The New England journal of medicine.

[10]  Loyd,et al.  SIMVASTATIN AND NIACIN , ANTIOXIDANT VITAMINS , OR THE COMBINATION FOR THE PREVENTION OF CORONARY DISEASE , 2001 .

[11]  E. Schouten,et al.  Serum carotenoids, alpha-tocopherol and mortality risk in a prospective study among Dutch elderly. , 2001, International journal of epidemiology.

[12]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.

[13]  E. Rimm,et al.  Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. , 1995, The American journal of clinical nutrition.

[14]  B. Frei.  Reactive oxygen species and antioxidant vitamins: mechanisms of action. , 1994, The American journal of medicine.

[15]  J. Cruysberg,et al.  Neovascular age-related macular degeneration and its relationship to antioxidant intake. , 2002, Acta ophthalmologica Scandinavica.

[16]  K. Ingold,et al.  beta-Carotene: an unusual type of lipid antioxidant. , 1984, Science.

[17]  R. Goldbohm,et al.  Epidemiologic evidence for β-carotene and cancer prevention , 1995 .

[18]  F. Granado,et al.  A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. , 2002, Clinical science.

[19]  P. Palozza,et al.  Prooxidant activity of β-carotene under 100% oxygen pressure in rat liver microsomes , 1995 .

[20]  B. Ames,et al.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. , 1983, Science.

[21]  S. Yusuf,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[22]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[23]  B Gullberg,et al.  Serum concentrations of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity. , 2001, The American journal of clinical nutrition.

[24]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[25]  N. Benowitz,et al.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids , 2000 .

[26]  L. Kohlmeier,et al.  Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. , 1995, The American journal of clinical nutrition.

[27]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[28]  J. Manson,et al.  Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. , 1999, Journal of the National Cancer Institute.

[29]  T. Byers,et al.  Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. , 1992, Annual review of nutrition.

[30]  P. Galan,et al.  Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study. , 1998, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[31]  J. Vuilleumier,et al.  Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part I: The fat-soluble vitamins A and E, and beta-carotene. , 1983, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[32]  P. Palozza,et al.  Prooxidant activity of beta-carotene under 100% oxygen pressure in rat liver microsomes. , 1995, Free radical biology & medicine.

[33]  B. Ames.  DIETARY CARCINOGENESIS AND ANTICARCINOGENESIS , 1983 .

[34]  A. Drewnowski,et al.  Serum beta-carotene and vitamin C as biomarkers of vegetable and fruit intakes in a community-based sample of French adults. , 1997, The American journal of clinical nutrition.

[35]  B. Sibbald,et al.  Health and Drug Alerts: Ephedra/ephedrine: cardiovascular and CNS effects , 2002 .

[36]  C. Steeh,et al.  Are They Really as Bad as They Seem? Nonresponse Rates at the End of the Twentieth Century , 2001 .

[37]  R B Ervin,et al.  Use of dietary supplements in the United States, 1988-94. , 1999, Vital and health statistics. Series 11, Data from the National Health Survey.

[38]  E. Topol,et al.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials , 2003, The Lancet.

[39]  Z. Gardner,et al.  American Herbal Products Association's botanical safety handbook , 1997 .

[40]  M. Brown,et al.  A Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: The Cambridge Heart Antioxidant Study (CHAOS) , 1996 .

[41]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[42]  R. Ziegler,et al.  Vegetables, fruits, and carotenoids and the risk of cancer. , 1991, The American journal of clinical nutrition.

[43]  J. Menke.  Herbal remedies. , 1997, South Dakota journal of medicine.

[44]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[45]  J. L. Greger.  Dietary supplement use: consumer characteristics and interests. , 2001, The Journal of nutrition.

[46]  J. Arnaud,et al.  Recommended method for assaying serum zinc with flame atomic absorption. , 1986, Annales de biologie clinique.

[47]  A. Mitchell,et al.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.

[48]  Hanyu Ni,et al.  Utilization of Complementary and Alternative Medicine by United States Adults: Results From the 1999 National Health Interview Survey , 2002, Medical care.

[49]  D. Rennie,et al.  The need for regulation of dietary supplements--lessons from ephedra. , 2003, JAMA.

[50]  A. Coats.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[51]  B. Hammond,et al.  Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. , 2001, The American journal of clinical nutrition.

[52]  J. Manson,et al.  β-Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study. , 1999, Journal of the National Cancer Institute.

[53]  J. Potter,et al.  Vegetables, fruit, and cancer prevention: a review. , 1996, Journal of the American Dietetic Association.

[54]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[55]  Tom W. Smith.  The Hidden 25 Percent: An Analysis of Nonresponse on the 1980 General Social Survey , 1983 .

[56]  W. Abebe,et al.  Herbal medication: potential for adverse interactions with analgesic drugs , 2002, Journal of clinical pharmacy and therapeutics.

[57]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[58]  P. Galan,et al.  Vitamin status of a healthy French population: dietary intakes and biochemical markers. , 1994, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.